A randomized clinical trial to evaluate the single‐dose pharmacokinetics, pharmacodynamics and safety of sitagliptin in pediatric patients with type 2 diabetes
Fraser IP et al. Pediatr Diabetes 2018. doi: 10.1111/pedi.12790
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.